Actinver Casa de Bolsa, S.A. de C.V. served as bookrunner for the transaction. The proceeds from these issuances will be used for the purposes outlined in the respective offering supplements for each ...
Genomma Lab Internacional SAB de CV (GNMLF) recently announced a dividend of $0.2 per share, payable on 2023-12-27, with the ex-dividend date set for 2023-12-22. As investors look forward to this ...
Genomma Lab Internacional, S.A.B. de C.V. is one of the leading pharmaceutical and personal care products companies in Mexico with an increasing international presence. Genomma Lab develops, sells and ...
At close: 20 May at 1:59:55 pm GMT-6 ...
MEXICO CITY, Feb. 25, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the fourth quarter and full year 2025.
Find the latest Genomma Lab Internacional, S.A.B. de C.V. (LABB.MX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Genomma Lab Internacional, S.A.B. de C.V. is one of the leading pharmaceutical and personal care products companies in Mexico with an increasing international presence. Genomma Lab develops, sells and ...
Genomma Lab Internacional, S.A.B. de C.V. is one of the leading pharmaceutical and personal care products companies in Mexico with an increasing international presence. Genomma Lab develops, sells and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results